U.S. and Pfizer Discuss Deal for Tens of Millions More Vaccine Doses Next Year

To Know more how you can benefit from the Muslim Times, go to our Homepage or About Us page

The Muslim Times has the best collection on the Muslim heritage, which is the best tool to refute Islamophobia and we also have the latest and the best about vaccines. Suggested reading: The Turkish Muslim Couple Behind the Pfizer Vaccine

Source: New York Times

The Trump administration is negotiating a deal to use its power to free up supplies of raw materials to help Pfizer produce tens of millions of additional doses of its Covid-19 vaccine for Americans in the first half of next year, people familiar with the situation said.

Should an agreement be struck, it could at least partially remedy a looming shortage that the administration itself arguably helped create by not pre-ordering more doses of the vaccine Pfizer developed with its German partner, BioNTech. Pfizer agreed this summer to provide the United States with 100 million doses by the end of March, enough to inoculate 50 million people since its vaccine requires two shots.

Here’s what you need to know:

The Pfizer vaccine is one of only two so far that have been proved to work. The Trump administration has locked in only enough doses of the two vaccines — the other, produced by Moderna, is on track to receive emergency authorization from the Food and Drug Administration this week — to cover 150 million people by the end of June, or less than half the nation.

The administration recently asked Pfizer to sell it enough doses to cover an additional 50 million Americans, but Pfizer said it had already found customers around the world for all the doses it can produce until around the middle of next year.

In recent days, however, Pfizer has indicated that it would be able to manufacture more doses if the administration orders the company’s suppliers to prioritize its purchase requests. The two sides are now negotiating a contract under which Pfizer would provide tens of millions more doses from April to the end of June.

According to one person familiar with the situation, Pfizer asked for that favored status with suppliers months ago. But before it was clear which vaccine trials would succeed, Trump administration officials were apparently worried about hindering other vaccine makers that had accepted billions of dollars in federal subsidies. Federal officials worked to prioritize orders for manufacturing supplies from those firms, including Moderna.

Read further

Categories: The Muslim Times

2 replies

  1. Millions of doses of Pfizer Inc (NYSE: PFE) and BioNTech SE’s (NASDAQ: BNTX) COVID-19 vaccine will be administered in China alongside home-made options, Bloomberg reported Tuesday.

    What Happened: Local pharmaceutical firm Shanghai Fosun Pharmaceutical (Group) Co, Ltd (OTC: SFOSF) — which signed an agreement with BioNTech in March — will pay the German company $300 million (EUR 250 million) for an initial 50 million doses, according to Bloomberg.

    Pfizer’s German partner will supply no less than 100 million doses to China by 2021, Fosun informed the Hong Kong Stock Exchange, as per Bloomberg.

    https://www.statnews.com/2020/12/17/moderna-vaccine-fda-panel/

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.